Renee Willmon and MG Registry featured in new Rare Disease Article Series
Alira Health’s Senior Director of Evidence and Outcomes Renee Willmon was recently featured in the new Rare Community Profiles series on Patient Worthy®. In the article, “Alira Health and the MGFA Partner to Develop a Myasthenia Gravis Registry,” Renee shares how her professional journey has led her to her current involvement in patient registry development.
Renee Willmon is the Registry Lead on the Alira Health side of the partnership with MGFA, and works with both teams to ensure that MG patients’ experiences are well-represented in the registry and that other stakeholders can access and use the data to improve the development of new treatments, and access to care for MG.
Patient Worthy® is an online publication that provides relevant information to rare disease patients, caregivers and advocates alike. Rare Community Profiles is a new Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their families, advocates, scientists, and more.
Alira Health Joins France Biotech as an Expert Partner
Webinar: How to Increase Patient Engagement in Your Clinical Trials
PSI 2023 Conference
World Orphan Drug Congress USA
How to Leverage Real-World Evidence to Achieve Orphan Drug Designation
XII Jornada Anual Programa Hospital Clínic de Enfermedades Minoritarias
Subscribe to our newsletter for the latest news, events, and thought leadership